Showing results (1-10 of 723) with videos related to
Sort By:
Pageof 73
Rheumatology (Oxford, England)|March 12, 2021
COVID-19 vaccination and antirheumatic therapyJack Arnold, Kevin Winthrop, Paul EmeryCurrent Opinion in Rheumatology|March 18, 2016
Vaccinations for rheumatoid arthritisMarcia A Friedman, Kevin WinthropThe Lancet. Rheumatology|January 30, 2023
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort studyMd Yuzaiful Md Yusof, Jack Arnold, Benazir Saleem, et al.Frontiers in Immunology|January 31, 2022
A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated VasculitisJack Arnold, Edward M Vital, Shouvik Dass, et al.ACR Open Rheumatology|June 6, 2022
Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren SyndromeSophanit Pepple, Jack Arnold, Edward M Vital, et al.Nature Reviews. Rheumatology|June 16, 2017
The role of IL-6 in host defence against infections: immunobiology and clinical implicationsStefan Rose-John, Kevin Winthrop, Leonard CalabreseDrugs of Today (Barcelona, Spain : 1998)|December 12, 2003
Role of adalimumab, a novel TNF antagonist in advancing rheumatoid arthritis controlPaul EmeryDrugs of Today (Barcelona, Spain : 1998)|May 11, 2005
Adalimumab therapy: clinical findings and implications for integration into clinical guidelines for rheumatoid arthritisPaul EmeryRheumatology (Oxford, England)|June 22, 2012
Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatmentPaul EmeryArthritis Research|July 12, 2002
Magnetic resonance imaging: opportunities for rheumatoid arthritis disease assessment and monitoring long-term treatment outcomesPaul EmeryPageof 73